Literature DB >> 16609885

[Muscle relaxants in Germany 2005: a comparison of application customs in hospitals and private practices].

H Fink1, G Geldner, T Fuchs-Buder, R Hofmockel, K Ulm, B Wallek, M Blobner.   

Abstract

Aim of this study was to evaluate application customs of muscles relaxants in hospitals compared to their use in private practice. Of the 3,260 questionnaires sent-out, 66.9% could be analyzed. Of these 54% were from anesthetists in private practice, 41% from heads of hospital anesthesia departments and 5% from heads of level one hospital anesthesia departments. The first difference between private practices and hospitals was the number of available muscle relaxants: 87% of private practices use 1-3 relaxants, whereas 79% of hospitals use 3-5. Another apparent difference was the relationship between general anesthesia and the number of intubations: 60% of private practices have over 80% of general anesthesia cases, but only 50% of these patients are intubated. On the contrary, two thirds of the hospitals have 50-80% general anesthesia cases and 60-70% of patients are intubated. The main wish for an ideal muscle relaxant was independent of private practice or hospital, short onset time, followed by fast recovery. In accordance 74% of anesthetists in hospitals and 72% of anesthetists in private practice voiced the wish for a non-depolarizing succinylcholine substitute. The results of this nationwide survey suggest that time pressure in combination with an increased specialization of anesthetists in private practice are the main factors for availability and use of muscle relaxants in routine anesthesia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16609885     DOI: 10.1007/s00101-006-1015-6

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  19 in total

Review 1.  [Rapid sequence induction with succinylcholine: an option to reduce side effects].

Authors:  M Blobner; R Busley; E Kochs
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2000-02       Impact factor: 0.698

2.  [Application of muscle relaxants in Germany. A survey of German anaesthesia departments].

Authors:  M Blobner; A-M Söhnel; A van de Roemer; H Bachmann; G Geldner; R Hofmockel; T Fuchs-Buder; C Diefenbach; K Ulm
Journal:  Anaesthesist       Date:  2003-05       Impact factor: 1.041

3.  [Application of muscle relaxants for rapid-sequence induction of anaesthesia].

Authors:  R Hofmockel; G Geldner; C Diefenbach; T Fuchs-Buder; K Ulm; M Blobner
Journal:  Anaesthesist       Date:  2003-06       Impact factor: 1.041

4.  Tracheal intubation with rocuronium using the "timing principle".

Authors:  T J Sieber; A M Zbinden; M Curatolo; G D Shorten
Journal:  Anesth Analg       Date:  1998-05       Impact factor: 5.108

5.  Pretreatment with atracurium: the influence on neuromuscular transmission and pulmonary function.

Authors:  P Howardy-Hansen; J Møller; B Hansen
Journal:  Acta Anaesthesiol Scand       Date:  1987-10       Impact factor: 2.105

6.  Precurarization--a hazard to the patient?

Authors:  J Engbaek; J Viby-Mogensen
Journal:  Acta Anaesthesiol Scand       Date:  1984-02       Impact factor: 2.105

7.  Pulmonary aspiration after a priming dose of vecuronium.

Authors:  J Musich; L F Walts
Journal:  Anesthesiology       Date:  1986-04       Impact factor: 7.892

8.  Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials.

Authors:  Jan-Uwe Schreiber; Christopher Lysakowski; Thomas Fuchs-Buder; Martin R Tramèr
Journal:  Anesthesiology       Date:  2005-10       Impact factor: 7.892

9.  [Precurarization of succinylcholine with cisatracurium: the influence of the precurarization interval].

Authors:  T Mencke; C Becker; J Schreiber; M Bolte; T Fuchs-Buder
Journal:  Anaesthesist       Date:  2002-09       Impact factor: 1.041

10.  [The use of muscle relaxants for routine induction of anesthesia in Germany].

Authors:  G Geldner; T Fuchs-Buder; R Hofmockel; C Diefenbach; K Ulm; M Blobner
Journal:  Anaesthesist       Date:  2003-05       Impact factor: 1.041

View more
  10 in total

Review 1.  [Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium].

Authors:  H J Sparr; L H Booij; T Fuchs-Buder
Journal:  Anaesthesist       Date:  2009-01       Impact factor: 1.041

2.  [Application of neuromuscular monitoring in Germany].

Authors:  T Fuchs-Buder; H Fink; R Hofmockel; G Geldner; K Ulm; M Blobner
Journal:  Anaesthesist       Date:  2008-09       Impact factor: 1.041

3.  [Precurarization with a non-depolarizing muscle relaxant].

Authors:  S Bugger
Journal:  Anaesthesist       Date:  2013-06       Impact factor: 1.041

4.  [When case studies must replace lacking evidence].

Authors:  M Blobner
Journal:  Anaesthesist       Date:  2012-08       Impact factor: 1.041

5.  Use of Succinylcholine by Anaesthetists in Turkey: A National Survey.

Authors:  Dilek Ömür; Hasan Ali Kiraz; Hasan Şahin; Hüseyin Toman; Berna Uyan; Serpil Ekin; Volkan Hancı
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-08-21

6.  [Priming technique with cisatracurium Onset time at the laryngeal muscles].

Authors:  J Schmidt; S Albrecht; N Petterich; J Fechner; P Klein; A Irouschek
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

7.  A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anesthesiologists.

Authors:  Abdelazeem Eldawlatly; Mohamed R El-Tahan
Journal:  Saudi J Anaesth       Date:  2013-04

8.  Intubating conditions and side effects of propofol, remifentanil and sevoflurane compared with propofol, remifentanil and rocuronium: a randomised, prospective, clinical trial.

Authors:  Thomas Mencke; Refa Maria Jacobs; Susann Machmueller; Martin Sauer; Christine Heidecke; Anja Kallert; Hans Wilhelm Pau; Gabriele Noeldge-Schomburg; Attila Ovari
Journal:  BMC Anesthesiol       Date:  2014-05-22       Impact factor: 2.217

9.  Sevoflurane at 1.0 MAC together with remifentanil and propofol produces clinically acceptable intubation conditions at the vocal cords: A prospective randomized study.

Authors:  Attila Ovari; Ilona Bicker; Susann Machmueller; Tobias Schuldt; Martin Sauer; Stefan Soltesz; Gabriele Noeldge-Schomburg; Robert Mlynski; Thomas Mencke
Journal:  J Int Med Res       Date:  2017-04-28       Impact factor: 1.671

10.  Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management.

Authors:  HaoTian Wu; ZengMao Lin; RuiHao Zhou; SuiSui Huang; LingJun Chen; Yang Su; LuoNa Cheng; Huan Zhang
Journal:  Front Med (Lausanne)       Date:  2022-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.